American Assets Investment Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,500
| Closed | -$276K | – | 163 |
|
|
2021
Q2 | $276K | Hold |
1,500
| – | – | 0.04% | 130 |
|
|
2021
Q1 | $229K | Hold |
1,500
| – | – | 0.03% | 147 |
|
|
2020
Q4 | $234K | Buy |
+1,500
| New | +$234K | 0.04% | 124 |
|
|
2020
Q2 | – | Sell |
-5,000
| Closed | -$449K | – | 171 |
|
|
2020
Q1 | $449K | Buy |
5,000
+1,500
| +43% | +$135K | 0.1% | 149 |
|
|
2019
Q4 | $379K | Hold |
3,500
| – | – | 0.06% | 164 |
|
|
2019
Q3 | $343K | Hold |
3,500
| – | – | 0.06% | 163 |
|
|
2019
Q2 | $458K | Hold |
3,500
| – | – | 0.07% | 158 |
|
|
2019
Q1 | $466K | Hold |
3,500
| – | – | 0.08% | 159 |
|
|
2018
Q4 | $341K | Hold |
3,500
| – | – | 0.06% | 162 |
|
|
2018
Q3 | $484K | Hold |
3,500
| – | – | 0.08% | 160 |
|
|
2018
Q2 | $426K | Buy |
3,500
+1,000
| +40% | +$122K | 0.07% | 162 |
|
|
2018
Q1 | $279K | Buy |
+2,500
| New | +$279K | 0.05% | 172 |
|